DALLAS, Texas, March 09, 2017 -- Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”) today filed its annual report on Form 10-K with the Securities and Exchange Commission for the year ended December 31, 2016.
The 10-K report is available to view, print or download on the Investors page of Southcross’ website at www.southcrossenergy.com. Southcross will also provide a printed copy of the annual report on Form 10-K free of charge upon request. Such requests should be directed in writing via email to [email protected] or via mail to Investor Relations, 1717 Main Street, Suite 5200, Dallas, TX 75201.
About Southcross Energy Partners, L.P.
Southcross Energy Partners, L.P. is a master limited partnership that provides natural gas gathering, processing, treating, compression and transportation services and NGL fractionation and transportation services. It also sources, purchases, transports and sells natural gas and NGLs. Its assets are located in South Texas, Mississippi and Alabama and include two gas processing plants, one fractionation plant and approximately 3,100 miles of pipeline. The South Texas assets are located in or near the Eagle Ford shale region. Southcross is headquartered in Dallas, Texas. Visit www.southcrossenergy.com for more information.
Contact: Southcross Energy Partners, L.P. Mallory Biegler, 214-979-3720 Investor Relations [email protected]


Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



